# An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With Lymphoma

> **NCT03779113** · PHASE1 · TERMINATED · sponsor: **Hutchmed** · enrollment: 69 (actual)

## Conditions studied

- Non Hodgkin Lymphoma

## Interventions

- **DRUG:** HMPL-523

## Key facts

- **NCT ID:** NCT03779113
- **Lead sponsor:** Hutchmed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-26
- **Primary completion:** 2025-02-26
- **Final completion:** 2025-02-26
- **Target enrollment:** 69 (ACTUAL)
- **Why stopped:** Study terminated by sponsor
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03779113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03779113, "An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With Lymphoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03779113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*